๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Targeting specific behavioral symptoms in Alzheimer's disease using carbamazepine: Results of a pilot, placebo-controlled, randomized, 6-week trial

โœ Scribed by Jason T. Olin; Lauren S. Fox; Sonia Pawluczyk; Nansi A. Taggart; Lon S. Schneider


Book ID
117411251
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
187 KB
Volume
21
Category
Article
ISSN
0197-4580

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A 6-month, randomized, double-blind, pla
โœ D.P. Devanand; Gregory H. Pelton; Karine Cunqueiro; Harold A. Sackeim; Karen Mar ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 215 KB ๐Ÿ‘ 2 views

## Abstract ## Objective In patients with Alzheimer's disease (AD) with psychosis or agitation that respond to haloperidol treatment, to evaluate the risk of relapse following discontinuation. ## Methods In outpatients with AD with symptoms of psychosis or agitation, responders to 20 weeks of ha